Objective: Our objective was to review the characteristics, current applications, and evaluation measures of conversational agents with unconstrained natural language input capabilities used for health-related purposes. Methods: We searched PubMed, Embase, CINAHL, PsycInfo, and ACM Digital using a predefined search strategy. Studies were included if they focused on consumers or healthcare professionals; involved a conversational agent using any unconstrained natural language input; and reported evaluation measures resulting from user interaction with the system. Studies were screened by independent reviewers and Cohen's kappa measured inter-coder agreement. Results: The database search retrieved 1513 citations; 17 articles (14 different conversational agents) met the inclusion criteria. Dialogue management strategies were mostly finite-state and frame-based (6 and 7 conversational agents, respectively); agent-based strategies were present in one type of system. Two studies were randomized controlled trials (RCTs), 1 was cross-sectional, and the remaining were quasi-experimental. Half of the conversational agents supported consumers with health tasks such as self-care. The only RCT evaluating the efficacy of a conversational agent found a significant effect in reducing depression symptoms (effect size d ¼ 0.44, p ¼ .04). Patient safety was rarely evaluated in the included studies. Conclusions: The use of conversational agents with unconstrained natural language input capabilities for health-related purposes is an emerging field of research, where the few published studies were mainly quasiexperimental, and rarely evaluated efficacy or safety. Future studies would benefit from more robust experimental designs and standardized reporting. Protocol Registration: The protocol for this systematic review is registered at PROSPERO with the number CRD42017065917.
INTRODUCTION
Advances in voice recognition, natural language processing, and artificial intelligence have led to the increasing availability and use of conversational agents-systems that mimic human conversation using text or spoken language. Familiar examples of conversational agents include voice-activated systems like Apple Siri, Google Now, Microsoft Cortana, or Amazon Alexa. 1 Some of the earliest examples of conversational agents were chatbots built with the aim of being indistinguishable from a human, in order to pass the Turing test. These systems were tested in experiments where human users would engage with them in conversation (typing in a computer) and decide whether they were talking to a human or a machine.
Over the last two decades, a solid body of evidence has shown the potential benefits of using embodied conversational agents for health-related purposes. Several randomized controlled trials of interventions involving embodied conversational agents have shown significant improvements in physical activity, fruit and vegetable consumption, and accessibility to online health information, among other outcomes. [3] [4] [5] [6] However, the majority of these agents only allowed for constrained user input (eg multiple-choice of utterance options), not having the capability to understand natural language input. A recent renewed interest in artificial intelligence has seen an increase in the popularity of conversational agents, particularly those with the capability to use any unconstrained natural language input. 7 Advances in machine learning, particularly in neural networks, has allowed for more complex dialogue management methods and more conversational flexibility. 8, 9 Given the development of increasingly powerful and connected devices, and growing access to contextual information (such as from sensors), smartphone conversational agents are now widely used by consumers for daily tasks like retrieving information and managing calendars.
In light of their expanding capabilities, conversational agents have the potential to play an increasingly important role in health and medical care, assisting clinicians during the consultation, supporting consumers with behavior change challenges, or assisting patients and elderly individuals in their living environments. 10, 11 These opportunities also come with potential safety issues, which can lead to patient harm. To our knowledge, no systematic review of the use of this technology in healthcare has been undertaken. In order to address this gap, our aim was to systematically identify and review studies of conversational agents that use any unconstrained natural language input for health-related purposes, focusing on their characteristics, applications, and evaluation methods.
METHODS
We focused our study on conversational agents that use any unconstrained natural language input, given their growing availability and use. Based on existing literature, there is a lack of consensus regarding the definitions of conversational agents, dialogue systems, embodied conversational agents, smart conversational interfaces, or chatbots. 1, 8, 9, 12, 13 Examples of conversational agents include (but are not limited to): chatbots, which have the ability to engage in "small talk" and casual conversation; embodied conversational agents, which involve a computer-generated character (eg avatar, virtual agent) simulating face-to-face conversation with verbal and nonverbal behavior; and smart conversational interfaces such as Apple Siri, Google Now, Microsoft Cortana, or Amazon Alexa. 1, 8, 9 For the purposes of this review, we considered the subset of conversational agents that use any unconstrained natural language input. Excluded systems were constrained input conversational agents using only non-natural language communication, which have been the focus of past reviews (eg embodied conversational agents where input occurs via multiple-choice of utterance options).
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Search strategy
A systematic search of the literature was performed in April 2017, and updated in February 2018, using PubMed, Embase, CINAHL, PsycInfo, and ACM Digital Library, not restricted by publication year or language. Search terms included "conversational agents," "dialogue systems," "relational agents" and "chatbots" (complete search strategy available in Supplementary Material S1). We also searched the reference lists of relevant articles. Grey literature identified in those databases (including dissertations, theses, and conference proceedings), were also included for screening.
Study selection criteria
We included primary research studies that focused on consumers, caregivers, or healthcare professionals; involved a conversational agent that used any unconstrained natural language input; and tested the system with human users. We excluded studies of systems where user input occurred by clicking or tapping an answer amongst a set of predefined choices, or by using the telephone keypad (eg interactive voice response systems with dual-tone multi-frequency); the output was not generated in response to what it received from the human user (eg predefined and pre-programmed messages); question-answer systems; and systems that used asynchronous communication technology such as email.
To be included, studies must also have reported evaluations based on human users interacting with the full system. Studies evaluating only individual components of the conversational agent-automatic speech recognition, natural language understanding, dialogue management, response generation, text-to-speech synthesis-were excluded. We also excluded studies using "Wizard of Oz" methods, where the dialog is generated by a human operator rather than the conversational agent.
Screening, data extraction, and synthesis
Screening procedures were piloted before the beginning of the screening process. Initial screening of articles was based on the information contained in their titles and abstracts and was conducted by 3 teams of 2 independent investigators. Full-text screening was conducted by the same investigator teams. Articles from search updates (April 2017 to February 2018) had their titles and abstracts screened by 1 investigator, and full-text screening by 2 independent investigators. Cohen's kappa was used to measure inter-coder agreement between individuals. Any remaining disagreements about inclusion or exclusion of an article were resolved by a third investigator.
The following data were extracted for each study: first author, year of publication, type of study, methods, type, and characteristics of the technology (Box 1), study duration (if applicable), participants' and setting characteristics, evaluation measures (Box 2), engagement measures (if applicable), and funding source.
Evaluation measures present in the included studies were extracted based on 3 types of evaluation: technical, user experience, and health research. Technical evaluation of a conversational agent included the objective assessment of the technical properties of the system as a whole and, where available, the evaluation of its individual components. 8, 14 User experience evaluation was considered a subjective assessment, where a group of users tested the system to judge its properties or components based on their personal opinions, 14 via qualitative (eg focus groups) or quantitative methods (eg surveys). 15 The evaluation of a conversational system from a health research perspective was considered to involve any health-related results present in the included studies, including process and outcome measures as defined by Donabedian; 16 for example, effectiveness in symptom reduction, diagnostic accuracy, or referrals. Two investigators reviewed all details extracted from the set of included studies for consistency; disagreements were resolved by a third investigator. Where applicable, trial quality was assessed using Cochrane's risk of bias tool.
interventions and study outcomes, a meta-analysis was not attempted. Instead, a narrative synthesis of the results was conducted 18 and conversational agents were characterized according to the categories defined in Box 1. The systematic review protocol was registered with PROSPERO, with number CRD42017065917. This systematic review is compliant with the PRISMA statement. 18 
RESULTS
The database search retrieved 1513 citations (Figure 1 ). After title and abstract screening, 1395 articles were excluded. We screened the full texts of the remaining 118 articles plus 3 additional articles identified in search updates. After full-text screening, 106 articles were excluded (see Supplementary Material S2), leaving 15 included studies. We identified a further 2 studies by searching the reference lists of included studies. The kappa statistic for the title and abstract screening was 0.45 (fair agreement) and 0.53 for the full-text screening (fair agreement) before consensus agreement was reached (Supplementary Material S3). 17 We included 17 studies evaluating 14 different conversational agents with unconstrained natural language input capabilities. 
Description of conversational agents
Yes
The system is designed for a particular task and set up to have short conversations, in order to get the necessary information to achieve the goal (eg booking a consultation) No
The system is not directed to the short-term achievement of a specific end-goal or task (eg purely conversational chatbots) Dialogue success rate (% successful task completion), dialogue-based cost measures (duration, number of turns necessary to achieve a task, number of repetitions, corrections or interruptions) Automatic speech recognition Word accuracy, word error rate, word insertion rate, word substitution rate, sentence accuracy Natural language understanding
Percentage of words correctly understood, not covered or partially covered; % sentences correctly analyzed; % words outside the dictionary; % sentences whose final semantic representation is the same as the reference; % correct frame units, considering the actual frame units; frame-level accuracy; frame-level coverage Dialogue management
Percentage of correct responses; % half-answers; % times the system works trying to solve a problem; % times the user acts trying to solve a problem Natural language generation Number of times the user requests a repetition of the reply provided by the system; user response time; number of times the user does not answer; rate of out-of-vocabulary words Speech synthesis Intelligibility of synthetic speech and naturalness of the voice The combination of architectures, initiatives, and dialogue management approaches are illustrated in Figure 2 . Finite-state dialogue management was used in the design of 6 conversational agents (8 studies), 20, 22, 23, [29] [30] [31] [32] 35 and for each of these, the dialogue system controlled the flow of the conversation (system initiative), often to support activities such as data collection for chronic disease management or facilitating diagnosis through a predefined clinical interview guide. Frame-based dialogue management was used in 7 agents (8 studies), 19, 21, 24, 25, 27, 28, 33, 34 and for these agents, both the human user and the agent were able to lead the conversation (mixed initiative). In the 1 conversational agent that used agent-based dialogue management, the user led the conversation (user initiative), asking questions related to mental and physical health. 26 Across the set of conversational agents we identified, taskoriented conversational agents were the most common (8 of 14, evaluated in 11 studies), where the goal was to assist a human user to complete a specific task. 20, 22, 23, 25, [29] [30] [31] [32] [33] [34] [35] Tasks included automating clinical diagnostic interviews, data collection, and telemonitoring. Among the task-oriented conversational agents, 6 (evaluated in 8 studies) used finite-state dialogue management, 20, 22, 23, [29] [30] [31] [32] 35 and frame-based dialogue management was used in the remaining 2 agents (evaluated in 3 studies). 25, 33, 34 The majority of the conversational agents we identified took spoken natural language as an input (10 of 14, evaluated in 13 studies), requiring speech recognition. [20] [21] [22] [23] 25, 26, [29] [30] [31] [32] [33] [34] [35] The remaining 4 conversational agents accepted written (typed) natural language. 19, 24, 27, 28 The most common output was also spoken natural language (7 of 14, evaluated in 10 studies). 22, 23, 25, [29] [30] [31] [32] [33] [34] [35] The remainder either used written natural language (4 of 14, evaluated in 4 studies), 19, 24, 27, 28 or a combination of written and spoken language (3 of 14, evaluated in 3 studies).
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Description of included studies
In the 17 included studies, conversational agents were used to support tasks undertaken by patients (Table 2) , clinicians, and both patients and clinicians (Table 3 25 A further 6 studies evaluated 3 different conversational agents used in applications supporting both clinicians and patients in telemonitoring and data collection. [30] [31] [32] [33] [34] The most common conditions were related to mental health, which was the focus of 6 studies (6 different conversational agents). 19, 20, 22, 24, 26, 35 Other conditions included asthma, 28 Most studies were quasi-experimental, involving the testing and evaluation of the conversational agents by users. Two studies were randomized controlled trials (RCTs) 19, 22 and one was cross-sectional. performance were the proportion of successful task completions (80-90% for 3 conversational agents) 25, [29] [30] [31] 33, 34 and recognition accuracy (70-97% for 2 conversational agents). 25, [29] [30] [31] User experience evaluation measures were generally related to overall satisfaction with the system, as well as usability and technical problems mentioned by the users. 19, [21] [22] [23] [24] [25] 27, 28, 30 All the studies evaluating satisfaction with the system reported high overall satisfaction 19, [21] [22] [23] [24] 28, 30 but only one of these studies used a validated questionnaire (Acceptability e-Scale). 22 Some of the most frequent user experience issues were related to spoken language understanding or dialogue Figure 2 . Characteristics of included conversational agents in terms of task-orientation, dialogue management, and dialogue initiative. 25 or not validated. 27 Most studies (11 of 17) evaluated and reported health research measures. 19, 20, [22] [23] [24] 26, [28] [29] [30] [31] 35 One RCT objectively measured patient-reported outcome measures (anxiety and depression symptoms) using validated scales, finding a significant decrease in symptoms of depression (effect size d ¼ 0.44, p ¼ .04). 19 Another study reported safety-related measures (eg inappropriate responses to suicide statements). 26 A crossover RCT evaluated the diagnostic performance for depression of an embodied conversational agent compared to a psychiatrist, finding a sensitivity of 49% and specificity of 93%. 22 One of the quasi-experimental studies (non-randomized) evaluated the diagnostic performance of an embodied conversational agent for excessive daytime sleepiness, in comparison to a sleep specialist, finding sensitivity and specificity values above 80%. 23 Three other studies assessed measures such as narrative skills, meditation frequency, and mental health symptoms disclosure; 20, 24, 35 and 4 studies (evaluating 2 different conversational agents) used qualitative methods to assess behavior change and adherence to self-management practices.
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DISCUSSION
Main findings
Despite the increasing use of conversational agents in other application domains, their use in healthcare is relatively rare. Evidence that this field is still in a nascent period of investigation comes from the timing of the studies (most published after 2010); the heterogeneity in evaluation methods and measures; and the predominance of quasi-experimental study designs over RCTs. Most of the research in the area evaluates task-oriented conversational agents that are used to support patients and clinicians in highly specific processes. The only RCT evaluating the efficacy of a conversational agent found a significant effect in reducing depression symptoms. 19 Two studies comparing diagnostic performance of conversational agents and clinicians found acceptable sensitivity and specificity.
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Comparisons with existing literature
To our knowledge, this is the first systematic review of conversational agents with unconstrained natural language input capabilities in healthcare. A recent scoping review of psychology-focused embodied conversational agents (where input was not strictly via natural language) found that most applications were still in the early stages of development and evaluation, 12 which is in line with our findings. A systematic review focusing on automated telephone communication systems (without natural language understanding) evaluated their effect in preventive healthcare and management of longterm conditions, finding that these systems can improve certain health behaviors and health outcomes. 37 Currently, conversational agents used in health applications appear to lag behind those used in other areas (eg travel information, restaurant selection and booking), where dialogue management and natural language generation methods have advanced beyond the rule-based approaches that were common in the studies we examined. 8, 38, 39 Rule-based approaches used in finite-state dialogue management systems are simple to construct for tasks that are straightforward and well-structured, but have the disadvantage of restricting user input to predetermined words and phrases, not allowing the user to take initiative in the dialogue, and making correction of misrecognized items difficult. 8, 36 This explains why studies in our review using finite-state dialogue management were all task-oriented, mostly focusing on information retrieval tasks such as data collection or following a predefined clinical interview guide. 20, 22, 23, [29] [30] [31] [32] 35 Frame-based systems address some of the limitations of finitestate dialogue management, by allowing for system and mixed initiative, as well as enabling a more flexible dialogue. 8, 36 Both methodologies are able to manage tasks based on the filling of a form by requesting data from the user. The main difference in frame-based systems is that they do not require following a predefined order to fill-in the necessary fields, enabling the user to provide more information than required by the system's question-the conversational agent keeps track of what information is required and asks its questions accordingly. In our review, the frame-based approach to dialogue management was found in 7 conversational agents (2 task-oriented and 5 not task-oriented), mostly for educational and data collection purposes. 19, 21, 24, 25, 27, 28, 33, 34 Unlike finite-state and frame-based systems, agent-based systems are able to manage complex dialogues, where the user can initiate and lead the conversation. 8 Agent-based methods for dialogue management are typically statistical models trained on corpora of real humancomputer dialogue, offering more robust speech recognition and performance, as well as better scalability, and greater scope for adaptation. 9, 36 Recent advances in machine learning and a renewed interest in neural networks have led to the development of much more complex and efficient conversational agents. 9, 40, 41 The use of agent-based dialogue management appears to be rare in health applications. We only identified one study that evaluated this type of conversational agent in the health context, and the agents were not designed specifically to answer health-related questions. 26 One of the major disadvantages of these systems-the fact that they require large training datasets-may be a reason for their slow adoption in health applications.
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Standards for reporting the evaluation of conversational agents in healthcare
Technical and user experience evaluation Until recently, the evaluation of individual components of dialogue systems was a common way of measuring their performance. 8 In order to evaluate these systems as a whole, additional measures are usually employed, such as dialogue success rates and dialogue costs (eg number of turns required to complete the task), as well as measures of user experience. 8, 43 The studies included in this review inconsistently reported technical evaluation measures for individual components of the conversational agent (eg speech recognition) and for the system as a whole. User experience evaluation measures were also reported inconsistently and were mostly assessed using non-validated questionnaires. This poses problems in the interpretation of the results, as well as in terms of comparison between different systems. Future studies should strive to report standard technical measures for evaluating a conversational assistant (Box 2), giving primacy to measures evaluating the system as a whole, as well as use validated questionnaires to assess user experience, in addition to qualitative methods of assessment.
Health research evaluation
We found that only one study evaluated the efficacy of a conversational agent on health outcomes using adequate study design methods (RCT) and validated questionnaires. 19 One other study used a randomized design (crossover RCT), evaluating the diagnostic performance of an embodied conversational agent. 22 The remaining studies used study designs with higher risk of bias, as well nonvalidated questionnaires or subjective measures, which make validation and generalizability of results challenging. 44, 45 In addition, we found inconsistencies in the reporting of: design methods (e.g. number of study arms, method of assignment, allocation ratio, blinding, outcome assessment, attrition); intervention details (characteristics of the conversational agent, including type of technology, dialogue management, dialogue initiative, input and output modalities, taskorientation); and conflicts of interest and funding sources. We recommend that future studies in the area follow standards of reporting such as the Consolidated Standards of Reporting Trials of electronic and mobile health applications and online telehealth (CONSORT-EHEALTH), 46 the Transparent Reporting of Evaluations with Nonrandomized Designs (TREND) statement, 47 and the Standards for Reporting Diagnostic accuracy studies (STARD), 48 among others from the Enhancing the Quality and Transparency Of health Research (EQUATOR) network. Reporting guidelines provide a basis for evaluating the validity of studies and comparing across interventions; and are important tools for achieving high standards in reporting health studies. Authors should additionally provide access to the conversational agent for testing, or facilitate access to sample dialogues to improve transparency in reporting and allow for independent replication studies to be conducted. 49, 50 Implications for healthcare, public health, and future research
Patient safety was rarely evaluated in the included studies. Miner et al. 26 was the only study we identified that considered safety issues,
showing that smartphone conversational agents often did not recognize or respond appropriately when they were being questioned about a serious health concern that might warrant immediate action. Unconstrained user input allows for more conversational flexibility but also comes with a higher risk for potential errors, such as mistakes in natural language understanding, response generation, or user interpretation of these responses. For example, a recent study of speech recognition for electronic health record documentation found an increased risk of errors, including errors with the potential to cause patient harm. 51 As such, more complex methods of verification of user input (or "grounding") may be needed, as well as a thorough evaluation of their ability to prevent errors. Furthermore, given the emerging state of the technology, evaluation studies should consistently assess and report any unexpected incidents resulting from the use of conversational agents for health-related purposes, including privacy breaches, technical problems, problematic responses, or patient harm. An important aspect of the impact of conversational agents in health is their unintended consequences. 52, 53 The effects of the implementation of information technology in a complex sociotechnical system such as healthcare can never be fully predicted and may lead to patient safety issues. 54 With increasing availability of large corpora of conversations and growing access to big health datasets (including patient-generated data collected from smartphone sensors and wireless tracking devices), 55 it is expected that deep learning methods and other agent-based dialogue management methods will be more widely adopted for health applications. As conversational agents become more competent and trustworthy, their utilization to automate tasks in the healthcare setting and in consumer self-care should increase, and should be systematically and continuously evaluated. The consequences of automation on human performance can pose serious safety concerns, with risks depending on the level of automation and the type of automated function. 10, 56, 57 Therefore, the use of conversational agents with unconstrained natural language input capabilities and other artificial intelligence applications in healthcare needs to be carefully monitored. 57, 58 Finally, a social-systems analysis is currently missing from research on conversational agents, an absence that has also been reported for artificial intelligence applications in previous literature. 59 There are currently no agreed methods to assess the long-term effects of this technology on human populations. Given the potential for bias in the design of these applications, they may contribute to reinforce stereotypes or disproportionally affect groups that are already discriminated against, based on gender, race, or socioeconomic background. The social impact of conversational agents should be consistently considered, from conception to real-world dissemination, given the potential to negatively influence the health of particular populations.
Strengths and limitations
This review has several strengths. We developed and followed a protocol that was registered in the PROSPERO database at the start of the study. We performed an extensive literature search, prioritizing sensitivity over specificity, so that important studies would not be missed. Eligibility criteria were objectively defined and applied in the screening of each study by two independent researchers.
The results of this review need to be interpreted in the context of some limitations. Our review focused on conversational agents that use any unconstrained natural language input, excluding conversational agents using constrained user input (eg multiple-choice of utterance options). Constrained input agents are relevant to healthcare applications but have been previously reviewed, 12 so we focused our review on agents with unconstrained natural language input capabilities. Cohen's kappa showed fair agreement in title and abstract screening, slightly improving in full-text screening. Inconsistencies in the reporting of intervention details, particularly in regards to the characteristics of the conversational agent (eg input and output modalities, natural language understanding), complicated eligibility criteria assessment, and led to disagreements between investigators, which might explain the mentioned kappa scores. Different typologies exist to characterize dialogue systems. 13 Our choice was based on the widespread use of the classification suggested by McTear. 8 The relatively small number of included studies, the heterogeneity of the conversational agents, and the predominance of quasiexperimental pilot studies reflect the maturity of the field, and this limited our ability to conduct a meta-analysis. Consequently, a narrative synthesis of results was conducted.
CONCLUSION
The use of conversational agents with unconstrained natural language input capabilities in healthcare is an emerging field of research that may have the potential to benefit health across a broad range of application domains, but evidence of efficacy and safety is still limited. Future research should strive to adhere to standards for reporting the characteristics of conversational agents and the methods for evaluating their safety and effectiveness.
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